MAM
SRPT icon

Meeder Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Meeder Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26
Closed -$1.66K – 1000
2025
Q1 		$1.66K Sell
26
-6
-19% -$632 ﹤0.01% 876
2024
Q4 		$3.89K Sell
32
-514
-94% -$63K ﹤0.01% 859
2024
Q3 		$68.2K Buy
546
+21
+4% +$2.9K ﹤0.01% 328
2024
Q2 		$83K Buy
525
+492
+1,491% +$63.2K 0.01% 278
2024
Q1 		$4.27K Buy
+33
New +$4.04K ﹤0.01% 650
2022
Q3 		– Sell
-4
Closed – – 2359
2022
Q2 		$0 Sell
4
-22
-85% -$1.62K ﹤0.01% 2418
2022
Q1 		$2K Buy
+26
New +$1.99K ﹤0.01% 2080
2021
Q4 		– Sell
-14
Closed -$1K – 2185
2021
Q3 		$1K Sell
14
-4
-22% -$308 ﹤0.01% 2372
2021
Q2 		$1K Sell
18
-1
-5% -$76 ﹤0.01% 2392
2021
Q1 		$1K Sell
19
-17
-47% -$1.57K ﹤0.01% 2263
2020
Q4 		$6K Buy
36
+1
+3% +$148 ﹤0.01% 1174
2020
Q3 		$5K Sell
35
-7
-17% -$1.06K ﹤0.01% 1593
2020
Q2 		$7K Sell
42
-25
-37% -$3.4K ﹤0.01% 1437
2020
Q1 		$7K Sell
67
-5
-7% -$572 ﹤0.01% 1671
2019
Q4 		$9K Buy
72
+45
+167% +$4.54K ﹤0.01% 1597
2019
Q3 		$2K Sell
27
-202
-88% -$23.9K ﹤0.01% 1984
2019
Q2 		$35K Sell
229
-4,980
-96% -$605K ﹤0.01% 1055
2019
Q1 		$620K Buy
5,209
+2,644
+103% +$340K 0.05% 343
2018
Q4 		$281K Buy
2,565
+2,416
+1,621% +$302K 0.03% 430
2018
Q3 		$24K Sell
149
-272
-65% -$37.2K ﹤0.01% 984
2018
Q2 		$55.6K Buy
+421
New +$39.7K ﹤0.01% 731
2018
Q1 		– Sell
-30
Closed -$2K – 1732
2017
Q4 		$2K Sell
30
-44
-59% -$2.33K ﹤0.01% 1505
2017
Q3 		$3K Buy
+74
New +$2.96K ﹤0.01% 1386
2017
Q2 		– Sell
-103
Closed -$3K – 1852
2017
Q1 		$3K Buy
+103
New +$3.19K ﹤0.01% 1280

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Meeder Asset Management's SRPT Position: Q2 2025 in Review

Meeder Asset Management sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 26 shares — an estimated $1.66K sold.

Meeder Asset Management first reported a position in SRPT in Q1 2017 and held it in 24 quarters. The position peaked at $620K in Q1 2019. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Meeder Asset Management reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Meeder Asset Management sold 26 Sarepta Therapeutics shares in Q2 2025, an estimated $1.66K.
  • Meeder Asset Management first reported a position in Sarepta Therapeutics in Q1 2017 and held it in 24 quarters.
  • Meeder Asset Management's Sarepta Therapeutics position peaked at $620K in Q1 2019.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Meeder Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.